Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages - PubMed (original) (raw)
Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages
Nazila Janabi. J Immunol. 2002.
Abstract
Overexpression of the inducible cyclooxygenase (COX-2) and inducible NO synthase (iNOS) in activated brain macrophages (microglia) and astrocytes appears central to many neuroinflammatory conditions. 15-Deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)) is a ligand for the peroxisome proliferator-activated receptor (PPAR)gamma. It has been proposed as an inhibitor of microglial activation, based on the study of iNOS down-regulation in rodent microglia. Because iNOS induction after cytokine activation remains controversial in human microglia, we examined the effect of 15d-PGJ(2) and other PPAR agonists on human microglia and astrocytes, using COX-2 induction as an index of activation. We found that PPAR alpha ligands (clofibrate and WY14643) enhanced IL-1 beta-induced COX-2 expression in human astrocytes and microglia, while inhibiting IL-1 beta plus IFN-gamma induction of iNOS in astrocytes. This is the first description of an inhibition of iNOS uncoupled from that of COX-2. 15d-PGJ(2) suppressed COX-2 induction in human astrocytes. It prevented NF-kappa B binding to the COX-2 promoter through a new pathway that is the repression of NF-kappa Bp50 induction by IL-1 beta. In contrast, 15d-PGJ(2) increased c-Jun and c-Fos DNA-binding activity in astrocytes, which may result in the activation of other inflammatory pathways. In human microglia, no effect of 15d-PGJ(2) on COX-2 and NF-kappa Bp65/p50 induction was observed. However, the entry of 15d-PGJ(2) occurred in microglia because STAT-1 and c-Jun expression was modulated. Our data suggest the existence of novel pathways mediated by 15d-PGJ(2) in human astrocytes. They also demonstrate that, unlike astrocytes and peripheral macrophages or rodent brain macrophages, human microglia are not subject to the anti-inflammatory effect of 15d-PGJ(2) in terms of COX-2 inhibition.
Similar articles
- PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts.
Simonin MA, Bordji K, Boyault S, Bianchi A, Gouze E, Bécuwe P, Dauça M, Netter P, Terlain B. Simonin MA, et al. Am J Physiol Cell Physiol. 2002 Jan;282(1):C125-33. doi: 10.1152/ajpcell.2002.282.1.C125. Am J Physiol Cell Physiol. 2002. PMID: 11742805 - Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
Farrajota K, Cheng S, Martel-Pelletier J, Afif H, Pelletier JP, Li X, Ranger P, Fahmi H. Farrajota K, et al. Arthritis Rheum. 2005 Jan;52(1):94-104. doi: 10.1002/art.20714. Arthritis Rheum. 2005. PMID: 15641079 - Cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) acts as a general inhibitor of inflammatory responses in activated BV-2 microglial cells.
Koppal T, Petrova TV, Van Eldik LJ. Koppal T, et al. Brain Res. 2000 Jun 9;867(1-2):115-21. doi: 10.1016/s0006-8993(00)02270-8. Brain Res. 2000. PMID: 10837804 - Hormone regulation of microglial cell activation: relevance to multiple sclerosis.
Drew PD, Storer PD, Xu J, Chavis JA. Drew PD, et al. Brain Res Brain Res Rev. 2005 Apr;48(2):322-7. doi: 10.1016/j.brainresrev.2004.12.020. Epub 2005 Jan 19. Brain Res Brain Res Rev. 2005. PMID: 15850670 Free PMC article. Review. - Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation.
Na HK, Surh YJ. Na HK, et al. Biochem Pharmacol. 2003 Oct 15;66(8):1381-91. doi: 10.1016/s0006-2952(03)00488-x. Biochem Pharmacol. 2003. PMID: 14555212 Review.
Cited by
- 15-Deoxy-Delta-12,14-prostaglandin J2 modulates pro-labour and pro-inflammatory responses in human myocytes, vaginal and amnion epithelial cells.
Rasheed ZB, Lee YS, Kim SH, Teoh T, MacIntyre DA, Bennett PR, Sykes L. Rasheed ZB, et al. Front Endocrinol (Lausanne). 2022 Sep 21;13:983924. doi: 10.3389/fendo.2022.983924. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36213265 Free PMC article. - Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells.
Ackerman WE 4th, Zhang XL, Rovin BH, Kniss DA. Ackerman WE 4th, et al. Biol Reprod. 2005 Sep;73(3):527-35. doi: 10.1095/biolreprod.104.039032. Epub 2005 Apr 20. Biol Reprod. 2005. PMID: 15843495 Free PMC article. - Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity.
Musiek ES, Milne GL, McLaughlin B, Morrow JD. Musiek ES, et al. Brain Pathol. 2005 Apr;15(2):149-58. doi: 10.1111/j.1750-3639.2005.tb00512.x. Brain Pathol. 2005. PMID: 15912888 Free PMC article. Review. - Cyclopentenone Prostaglandins: Biologically Active Lipid Mediators Targeting Inflammation.
Lee BR, Paing MH, Sharma-Walia N. Lee BR, et al. Front Physiol. 2021 Jul 15;12:640374. doi: 10.3389/fphys.2021.640374. eCollection 2021. Front Physiol. 2021. PMID: 34335286 Free PMC article. Review. - 15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells.
Nikitakis NG, Siavash H, Hebert C, Reynolds MA, Hamburger AW, Sauk JJ. Nikitakis NG, et al. Br J Cancer. 2002 Dec 2;87(12):1396-403. doi: 10.1038/sj.bjc.6600618. Br J Cancer. 2002. PMID: 12454768 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous